CHAMGAP
VERIFIEDPassed the Codex final verification and publication gate. Evidence-verification cutoff: 2026-07-09. AI was used for research and drafting; the existence of all 3 cited sources was verified at the original page, followed by blind grading, adversarial audit, and build validation. Methodology v1.0.
Verdict No. 171 · Search date 2026-07-09 · Methodology v1.0

Celery seed extract,
does it really help with Blood pressure?

30-Second Summary
C
Evidence Grade C · 40 · Safety caution
There is an early blood-pressure signal, but it is at the level of a single small study.
What the
research shows
Celery seed extract has only shown the possibility of lowering blood-pressure values in a single small trial in adults with hypertension. Blood pressure is a surrogate marker, so the maximum is C, and current human evidence is centered on a single small trial plus preclinical mechanisms for 3nB, with insufficient independent large-scale replication.
What the
ads claim
Advertising mentions 'blood pressure management,' 'natural diuretic,' 'vascular relaxation,' '3nB,' and 'swelling.'
*

Useful facts when choosing a product

  • Celery seed extract, celery powder, and celery juice cannot be viewed as having the same evidence.
  • When combined with antihypertensive drugs or diuretics, low blood pressure or electrolyte problems should be considered.
  • Caution is needed for celery allergy and Apiaceae-family allergy.
  • Medicinal doses during pregnancy and lactation are generally advised against.
ID

Chamgap Semantic Classification Code

Candidate index · review held

S.celery-seed-extract.UNK.blood-pressure.assess.placebo

Supplements and nutraceuticals > Celery seed extract > Unknown > Blood pressure > Association or change assessment > Placebo

An automated migration candidate, not an issued permanent code; exact claim scope remains under review. This machine-generated migration candidate helps retrieval but is not a permanent assignment. The original verdict ID and URL remain authoritative.

Download semantic index (JSON) · Codebook v1

Gap Measurement · Verdict 171 · C 40
What advertising claims
What independent, higher-quality research supports
△ GAP
01

What the research actually shows

A double-blind placebo-controlled study cited as 2022 reported the possibility of reduced systolic and diastolic blood pressure after 4 weeks of celery seed capsule intake in about 52-54 adults with hypertension. However, this is only a single small study, and standardization of 3nB, product independence, long-term safety, and independent large-scale replication are limited. Blood-pressure-related mechanisms of 3-n-butylphthalide mainly come from animal and pharmacology data.

02

Why this is classified as C (40)

The possibility of lowering blood-pressure values is at the level of a single small study. Blood pressure is a surrogate marker, so the maximum is C, and because independent large replication and clinical-event evidence are absent, this is lower-end C, 40 points.

Counterpoint. The blood-pressure reduction signal from the early study cannot be ignored, but because it is a single small result, it should be viewed conservatively until replication is confirmed.

Rejudgment record. Final — Blood pressure is a surrogate marker, so the maximum is C; evidence centers on a single small human trial and preclinical 3nB mechanisms, with insufficient independent large-scale replication

✓

Cross-check — AI research and Codex final gate

AI was used for research and drafting. Blind grading, adversarial audit, and the methodology boundary rules were then reapplied before Codex performed the final evidence, grade, copy, and build checks. If a grade cannot be narrowed, both evidence positions and their reasons are published.
03

Evidence Table

StudyDesignSampleFundingEndpointResultWeight
Celery seed capsule hypertension RCT. 2022Randomized double-blind placebo-controlled trial54UnknownSystolic and diastolic blood pressureAfter 4 weeks, reductions of about -11.08 mmHg systolic and about -6.54 mmHg diastolic were reported.Core
Tsi D, Tan BKH. 1997Animal pharmacology studyspontaneously hypertensive ratsUnknownBlood pressure and cardiovascular pharmacologySuggested possible blood-pressure-related mechanisms of 3-n-butylphthalide.Background
§

Receipt — 3 References

All 3 cited sources were verified for existence at the original page (as of 2026-07-09).

Clinical trial summarized in 2025-2026 celery seed reviews: celery seed capsules, 4 weeks, hypertensive adults, placebo-controlled; reported SBP -11.08 mmHg and DBP -6.54 mmHg.
checked
Tsi D, Tan BKH. Cardiovascular pharmacology of 3-n-butylphthalide in spontaneously hypertensive rats. Phytother Res. 1997.
checked
Diao X, Deng P, Xie C, et al. Metabolism and pharmacokinetics of 3-n-butylphthalide (NBP) in humans. Drug Metab Dispos. 2013;41:430-444. DOI: 10.1124/dmd.112.048561.
checked
Research and draft: AI used · Cross-check: blind grading and adversarial audit
Final verification and publication gate: Codex · Evidence date: 2026-07-09 · Corrections: none
↗

Cite this verdict

Celery seed extract (3nB) × blood pressure Evidence Grade C card
[Chamgap] Celery seed extract (3nB) × blood pressure — Evidence Grade C·40. 3 cited sources checked. Source: https://chamgap.com/en/verdicts/heart/celery-seed-extract-blood-pressure/ · CC BY 4.0

CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.

!

What this document does and does not do

Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.
↑